Peter Ulrichts
10Patents
5h-index
17Co-inventors
55Inventor score
Filing activity: Mar 16, 2012 → Jun 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8834882B2 | Antibodies to CD70 | Chemistry; Metallurgy | 28 | Active |
| US9765148B2 | Antibodies to CD70 | Chemistry; Metallurgy | 22 | Active |
| US9765149B2 | Antibodies to CD70 | Chemistry; Metallurgy | 21 | Active |
| US10316073B2 | FCRN antagonists and methods of use | Chemistry; Metallurgy | 6 | Active |
| US9926364B2 | Chimeric human-llama antigens and methods of use | Chemistry; Metallurgy | 5 | Active |
| US11505585B2 | FcRn antagonists and methods of use | Chemistry; Metallurgy | 4 | Active |
| US12202900B2 | Compositions and methods for treating immune thrombocytopenia | Chemistry; Metallurgy | 2 | Active |
| US12240875B2 | Use of FCRN antagonists for treatment of generalized myasthenia gravis | Chemistry; Metallurgy | 2 | Active |
| US11072665B2 | Antibodies to CD70 | Chemistry; Metallurgy | 2 | Active |
| US11434298B2 | Antibodies to CD70 | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.